Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aevit is a combination pharmaceutical preparation containing high doses of Vitamin A (retinol palmitate) and Vitamin E (alpha-tocopherol acetate). It is widely utilized in Eastern Europe for the treatment of conditions associated with vitamin deficiencies and for diseases requiring enhanced antioxidant support. Vitamin A is critical for maintaining the integrity of epithelial tissues, supporting visual function, and regulating cell differentiation through its interaction with nuclear receptors. Vitamin E acts as a potent lipid-soluble antioxidant, protecting cellular membranes from lipid peroxidation and synergistically enhancing the biological activity of Vitamin A. The product is indicated for a variety of conditions, including atherosclerosis, peripheral vascular disorders, and dermatological diseases such as psoriasis and ichthyosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on retinol + alpha-tocopherol.